U.S. senators press Mylan on 'exorbitantly expensive' EpiPen

WASHINGTON, Aug 30 (Reuters) - Democrat Elizabeth Warren and

19 other U.S. senators voiced concern to the chief executive of

Mylan NV about the high cost of its EpiPen on Tuesday,

calling the device used in the case of life-threatening

allergies "exorbitantly expensive."

Read more